SEC Form 4 · accession 0001193125-26-274178
TransMedics Group, Inc. · TMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Gunderson
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001756262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2026 | M | 19,285 | $2.21 | A | 26,266 | D | |
| Common Stock | Jun 15, 2026 | S | 9,624 | $75.06 | D | 16,642 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.21 | Jun 15, 2026 | M | 19,285 | D | — | Aug 1, 2026 | Common Stock | 19,285 | 0 | D |
Explanation of responses
- F1The shares were sold to cover the exercise price and applicable tax withholding obligations in connection with the exercise of the stock options.
- F2The stock options were granted on August 1, 2016 and are fully vested.